SCHEMBL3865859

SCHEMBL3865859

C#CCC(CP(=O)(O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)OC(C)(C)C

nearest known ligand 0.66

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ECE1 P42892 18/20 0.66
MME P08473 16/20 0.66
MMP8 P22894 1/20 0.55
MMP14 P50281 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3862345 0.94 ECE1 (0.59) ECE1MMEMMP8MMP14
SCHEMBL3862348 0.94 ECE1 (0.59) ECE1MMEMMP8MMP14
SCHEMBL6927137 0.84 ECE1 (0.72) ECE1MME
SCHEMBL3865857 0.84 ECE1 (0.68) ECE1MME
SCHEMBL13866600 0.82 ECE1 (0.62) ECE1MMEMMP8MMP14
SCHEMBL3868361 0.82 ECE1 (0.62) ECE1MMEMMP8MMP14
SCHEMBL6925939 0.82 ECE1 (0.88) ECE1MME
SCHEMBL4875022 0.81 ECE1 (0.83) ECE1MME
SCHEMBL3862254 0.81 MME (0.75) ECE1MMEMMP8MMP14
SCHEMBL3862257 0.81 MME (0.75) ECE1MMEMMP8MMP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7521469-B2 Phosphinic amino acid compounds LES LABORATOIRES SERVIER (FR) 2009-04-21 US disclosed
US-20080153890-A1 Phosphinic Amino Acid Compounds LES LABORATOIRES SERVER (FR) 2008-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080153890-A1 Phosphinic Amino Acid Compounds NPR1, NPPA, AADAT ECE1 419/4885MME 1899/4885MMP8 4401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.